‘Made in India’ research initiative to seek to develop a vaccine against Covid-19 based on multi-antigenic approach Kumar Jeetendra | April 30, 2020 Based on the biotech firm’s exclusive D-Crypt™ technology, this research methodology employs a modified version of baker’s yeast to produce the three antigens in a single host, thus making the potential vaccine easier to produce at mass scale and in a cost-effective manner compared to certain other vaccine candidates under development A team of researchers …
COVID-19 antibody chase warms up universally, still no assurance Kumar Jeetendra | May 4, 2020 Many individuals are focusing in nations over the world to be infused with test antibodies that may stop COVID-19, prodding trust possibly ridiculous that a conclusion to the pandemic may show up sooner than foreseen. Around 100 research bunches are seeking after immunizations with about twelve in beginning times of human preliminaries or ready to …
Rundown of WHO’s main 8 contenders for COVID-19 antibody Kumar Jeetendra | May 22, 2020 Five months into the worldwide flare-up of COVID-19, the world is attempting to beat the clock to set up an antibody for treating coronavirus patients. World Health Organisation(WHO) has recognized top eight contender for the coronavirus antibody: CanSino Biological Inc/Beijing Institute of Biotechnology: The Chinese antibody has been named as a top contender by WHO. …
XL-protein and Antlia Bioscience Announce Collaboration to Develop Long-acting Peptide Therapy of Chronic Heart Failure using PASylation® Technology Kumar Jeetendra | October 22, 2020 SAN DIEGO, U.S.A., and FREISING, Germany, October 15, 2020 – Life Science Newswire – Antlia Bioscience, Inc., a privately owned biopharmaceutical company located in San Diego, California, and XL-protein GmbH, a privately owned biopharmaceutical company located in Germany, are pleased to announce a strategic slliance using XL-protein’s proprietary PASylation® technology for plasma half-life extension to …
The founder of Bharat Biotech advocates for incentives, tax advantages, and innovation Kumar Jeetendra | January 21, 2023 Dr. Krishna Ella, the founder of Bharat Biotech, advocated on Friday for “research connected incentives” and tax breaks for new goods based on ground-breaking and patented invention carried out within the nation. “Research linked incentive for Indian companies is very important. I would request the ministry to give tax breaks to any product that is …
